Matches in Nanopublications for { ?s ?p "[Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 13 of
13
with 100 items per page.
- NP540556.RAv_Jppew5wBe09C6LWlROLWW4e9ZHa-k39pJzgbC8Qzk130_assertion description "[Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP540556.RAv_Jppew5wBe09C6LWlROLWW4e9ZHa-k39pJzgbC8Qzk130_provenance.
- NP586861.RA2hhRls7R1QTrvbXm5M1uAvhinabaIadH5lNULrD0l0A130_assertion description "[Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP586861.RA2hhRls7R1QTrvbXm5M1uAvhinabaIadH5lNULrD0l0A130_provenance.
- NP558088.RA1Ih2ApBY4JcaI05N9KWuxiPZEGmjAIW3R098hAS3VkA130_assertion description "[Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP558088.RA1Ih2ApBY4JcaI05N9KWuxiPZEGmjAIW3R098hAS3VkA130_provenance.
- NP670262.RA0rnCBDq19L6CqCBu7Neop5frns17cRF5ECBYpknDPF8130_assertion description "[Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP670262.RA0rnCBDq19L6CqCBu7Neop5frns17cRF5ECBYpknDPF8130_provenance.
- NP847436.RAz9uIdrETIEldkHn3HwYEnbbf91ucSN6Vq7a70M6vOTQ130_assertion description "[Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP847436.RAz9uIdrETIEldkHn3HwYEnbbf91ucSN6Vq7a70M6vOTQ130_provenance.
- NP750121.RAQ8olwJY14ohGcoIXpwRFkqS-YfYN8NdkjWdwaiA-4W4130_assertion description "[Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP750121.RAQ8olwJY14ohGcoIXpwRFkqS-YfYN8NdkjWdwaiA-4W4130_provenance.
- NP750122.RAdpWSBDJVLH6aNyz37ReDiDqDFDEoDiHHqIUfIFRKb-s130_assertion description "[Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP750122.RAdpWSBDJVLH6aNyz37ReDiDqDFDEoDiHHqIUfIFRKb-s130_provenance.
- assertion description "[Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP750120.RAoaGyjCTb7C0PZeaN5_6Jfi0EmqXi2aR37iaD0KNFuWI130_assertion description "[Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP750120.RAoaGyjCTb7C0PZeaN5_6Jfi0EmqXi2aR37iaD0KNFuWI130_provenance.
- NP998861.RAP3r7QpIDpAHzX9V_HtMKoLL6g3uZXZfigv5crvzeMZ0130_assertion description "[Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP998861.RAP3r7QpIDpAHzX9V_HtMKoLL6g3uZXZfigv5crvzeMZ0130_provenance.
- NP998897.RAN09vnRw9IjDjJMN8h99x591yVOOYgyvvC6NgIp_b6Wk130_assertion description "[Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP998897.RAN09vnRw9IjDjJMN8h99x591yVOOYgyvvC6NgIp_b6Wk130_provenance.